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Incidence, Severity and Prognosis Associated with Hypernatremia in
Dogs and Cats
Y. Ueda, K. Hopper, and S.E. Epstein
Background: Hypernatremia has been associated with substantial morbidity and death in human patients. The incidence
and importance of hypernatremia in dogs and cats has not been determined.
Hypothesis/Objectives: To describe the incidence of and prognosis associated with hypernatremia in dogs and cats at a
university teaching hospital.
Animals: A total of 16,691 dogs and 4,211 cats with measured blood or serum sodium concentration.
Methods: Retrospective study. Medical records of animals with a blood or serum sodium concentration measured during a
60-month period were reviewed to determine the severity of hypernatremia and its associated case fatality rate. Cases with
moderate (11–15 mmol/L above the reference range) or severe hypernatremia (≥16 mmol/L above the reference range) were
further reviewed.
Results: A total of 957 dogs (5.7%) and 338 cats (8.0%) were diagnosed with hypernatremia. Case fatality rates of dogs
and cats with hypernatremia was 20.6 and 28.1%, respectively compared to 4.4 and 4.5% with a normal blood or serum
sodium concentration (P < .0001). The magnitude of hypernatremia was linearly associated with a higher case fatality rate
(P < .0001). Hypernatremia was associated with a higher case fatality rate than hyponatremia. Among the animals with
moderate or severe hypernatremia, 50% of dogs and 38.5% of cats presented with community-acquired hypernatremia, and
50% of dogs and 61.5% of cats developed hospital-acquired hypernatremia.
Conclusions and clinical importance: Hypernatremia was found infrequently in this population but was associated with
increased case fatality rates in dogs and cats. Presence and severity of hypernatremia might be useful as a prognostic
indicator.
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Hypernatremia has been associated with substantialmorbidity and death in human patients.1,2 The
incidence of hypernatremia is 1–3% in all hospitalized
human patients and 6–26% in patients treated in medi-
cal and surgical intensive care units (ICU).3–10 Among
human ICU patients with hypernatremia only 23% had
hypernatremia present on admission and 77% of
patients developed hypernatremia during the ICU
stay.7,11 Hypernatremia on admission or acquired dur-
ing hospitalization was found to be an independent risk
factor for fatality rate in these studies.7,11 Even mild
increases in serum sodium levels have been associated
with increased fatality rate compared with normonatre-
mic human patients.10,11
To date, no studies have reported the overall inci-
dence, animal characteristics or causes of hypernatremia
in veterinary medicine. The objective of this retrospec-
tive study was to evaluate the epidemiology of hyper-
natremia, primarily focusing on the overall incidence of
this abnormality, concurrent underlying diseases and
potential pathophysiologic factors contributing to devel-
opment of hypernatremia, and the associated morbidity
and fatality rate in dogs and cats.
Materials and Methods
We used computerized medical records to identify all dogs and
cats that had blood or serum sodium concentration measured on a
blood gas determination or serum chemistry profile during a 60-
month period (January 1, 2008 to December 31, 2012) at the Uni-
versity of California, Davis, William R. Pritchard, Veterinary
Medical Teaching Hospital. This study included any dogs and cats
that had a blood or serum sodium concentration measured at our
institution during the specified time period.
Measurements
Blood or serum samples for sodium concentrations were mea-
sured using a point-of-care blood gas analyzera or 1 of 2 diagnos-
tic laboratory biochemical analyzers.b,c At our institution,
heparinized blood samples are measured for sodium as well as acid
base parameters and other electrolytes immediately after sample
collection using a point-of-care blood gas analyzer.a Alternatively,
serum is submitted to the diagnostic laboratory for analysis within
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12 hour of sample collection. Using the point-of-care blood gas
analyzer, the reference range for blood sodium concentration in
dogs and cats were 145–153 and 150–155 mmol/L, respectively.
Using the diagnostic laboratory, the reference range for the
sodium concentration in dogs were 143–151 mmol/L before Janu-
ary 05, 2011 and 145–154 mmol/L thereafter. The reference range
for serum sodium concentration in cats using the diagnostic labo-
ratory was 151–158 mmol/L throughout the study period.
The medical records of all identified dogs and cats with at least
1 blood or serum sodium concentration measured were reviewed
to determine the overall incidence and outcome of those animals
with hypernatremia. Animals with a blood or serum sodium con-
centration greater than the reference range were identified and cat-
egorized as borderline (≤5 mmol/L higher than the highest
reference concentration), mild (6–10 mmol/L higher than the high-
est reference concentration), moderate (11–15 mmol/L higher than
the highest reference concentration), or severe (≥16 mmol/L higher
than the highest reference concentration) hypernatremia. The cate-
gorization used for severity of hypernatremia was chosen based on
previous studies in human patients with some minor modifica-
tions.10,11 Animals with a blood or serum sodium concentration
lower than the reference range were categorized as hyponatremia
in a similar manner and these results are presented in a companion
article.12 Animals could only be enrolled in the study once and
only the first occurrence of hypernatremia identified in hospital
was included. The medical records of identified animals with mod-
erate or severe hypernatremia were further reviewed to determine
the primary disease processes, potential pathophysiologic factors
contributing to the development of hypernatremia, time of onset
(community versus hospital-acquired), presence or absence of
treatment given by referring veterinarian before presentation,
hydration status, intravascular volume status, and clinical signs
noted when the animals developed hypernatremia. The primary
disease process was determined by the primary clinicians and cate-
gorized based on major organ system affected (respiratory,
cardiovascular, neurological, musculoskeletal, gastrointestinal, he-
patobilliary, urological, pancreatic, and reproductive systems). The
specific diseases of neoplasia, diabetes mellitus and sepsis were
included separately either because they have multi-organ effects
and could not be simply categorized to an organ system or
because they have specific relevance to hypernatremia. In addition,
efforts were made to keep the categories used for primary disease
processes consistent for both hypernatremia and hyponatremia12
studies to facilitate comparison between the 2 groups of animals.
If hypernatremia was detected on the first blood sample in an
admission period and no medical treatment was given by a refer-
ring veterinarian before presentation, it was categorized as com-
munity-acquired. If hypernatremia was not evident on admission
blood sampling but was detected at a later point during hospital-
ization, it was categorized as hospital-acquired. In animals that
had hypernatremia on admission but had received medical treat-
ment by a referring veterinarian before presentation, the time of
onset of hypernatremia was classified unknown. Hydration and
intravascular volume status were based on the clinicians’ descrip-
tion of the animals in the medical records on the day hypernatre-
mia was first noted. The medical record also was searched for
evidence of any predefined pathophysiologic factors considered to
be possible contributors to the development of hypernatremia.
Clinical signs noted when hypernatremia was detected were
retrieved from the history and physical examination findings when
the animals developed hypernatremia.
Statistical Analysis
The proportion of animals that either died or were euthanized
that had hypernatremia at least once upon admission or during
hospitalization, was compared to animals with a normal sodium
concentration by Chi-square analysis using commercially available
software.d Animals with hyponatremia were excluded from this
analysis. Animals then were stratified into either severe, moderate,
mild, borderline hypernatremia, or normal sodium concentration.
The degree of sodium abnormality and outcome were compared
by Chi-square analysis for trend. In post hoc analysis, case fatality
rate for borderline hypernatremia was compared to case fatality
rate of animals with a normal sodium concentration by Chi-square
analysis. P < .05 was considered significant.
Results
During the 60-month study period, 16,691 dogs and
4,211 cats were identified in which ≥1 blood samples
were analyzed for blood or serum sodium concentra-
tion. Of these 957 (5.7%) dogs and 338 (8.0%) cats
were classified as having hypernatremia. The animal dis-
tributions in the categories of hypernatremia are listed
in Table 1. The highest sodium concentration measured
was 188 mmol/L in dogs and 214 mmol/L in cats.
Case fatality rates in dogs and cats with hypernatre-
mia were 20.6% (197/957) and 28.1% (95/338) respec-
tively. This is in comparison to case fatality rates of
4.4% (500/11,480) in dogs and 4.5% (81/1,792) in cats
with a normal sodium concentration, and case fatality
rates associated with hyponatremia of 13.7% (581/
4,254) in dogs and 11.9% (248/2,081) in cats from the
same population.12 Hypernatremia was associated with
a higher case fatality rate than having a normal sodium
concentration or hyponatremia in both dogs and cats
(P < .0001). The odds ratio (95% CI) of nonsurvival
with all degrees of hypernatremia was 5.7 (4.8–6.8) in
dogs and 8.3 (6.0–11.4) in cats. In addition, the magni-
tude of hypernatremia was linearly associated with
higher case fatality rate in both dogs and cats
(P < .0001; Fig 1). Borderline hypernatremia in both
dogs and cats was associated with nonsurvival
(P < .0001).
Among the animals with moderate or severe hyper-
natremia, 71.4% (40/56) dogs could be classified accord-
ing to the timing of development of hypernatremia. Of
Table 1. Incidence of abnormal blood or serum
sodium concentration in dogs and cats at a veterinary
medical teaching hospital.
Dogs N (%) Cats N (%)
Total 16,691 4,211
Normal sodium 11,480 (68.8) 1,792 (42.6)
All hypernatremia 957 (5.7) 338 (8)
Severe 27 (0.2) 10 (0.2)
Moderate 29 (0.2) 10 (0.2)
Mild 105 (0.6) 45 (1)
Borderline 796 (4.8) 273 (6.5)
All hyponatremia 4,254 (25.5) 2,081 (49.4)
Borderline hypernatremia, ≤5 mmol/L higher than the highest
reference concentration; mild hypernatremia, 6–10 mmol/L higher
than the highest reference concentration; moderate hypernatremia,
11–15 mmol/L higher than the highest reference concentration;
severe hypernatremia, ≥16 mmol/L higher than the highest refer-
ence concentration.
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these dogs, 50% (20/40) presented with community-
acquired whereas 50% (20/40) of dogs developed hospi-
tal-acquired hypernatremia. Twenty eight percent of
dogs (16/56) had received medical treatment by a refer-
ring veterinarian before presentation to our hospital
and the time of onset of hypernatremia was considered
unknown. In cats with moderate or severe hypernatre-
mia, 65% (13/20) could be classified according to the
timing of development of hypernatremia. Of these,
38.5% (5/13) presented with community-acquired and
61.5% (8/13) developed hospital-acquired hypernatre-
mia. Thirty-five percent of cats (7/20) had received med-
ical treatment by a referring veterinarian before
presentation to our hospital and the time of onset of
hypernatremia was considered unknown.
The primary disease processes of the animals with
moderate or severe hypernatremia are shown in
Table 2. The most frequent disease processes identified
in dogs were neurological (14/56, 21.4%), neoplastic
(12/56, 21.4%), and respiratory (11/56, 19.6%). In cats
with moderate or severe hypernatremia, the most fre-
quent disease processes were urological (11/20, 55%),
neurological (5/20, 25%), and hyperthyroidism (4/20,
20%). In both dogs and cats, many animals had ≥1
concurrent disease process.
Pathophysiologic factors potentially contributing to
the development of hypernatremia are shown in
Table 3. In dogs, gastrointestinal (GI) fluid loss caused
by vomiting and diarrhea was the most common identi-
fied factor (22/56, 39.3%), followed by central diabetes
insipidus (CDI) (13/56, 23.2%), and fever or hyperther-
mia (13/56, 23.2%). In cats, the most common patho-
physiologic factors potentially contributing to the
development of hypernatremia were chronic kidney dis-
ease (6/20, 30%) and nonoliguric acute kidney injury
(5/20, 25%), followed by GI fluid loss (5/20, 25%).
Many animals had ≥1 pathophysiologic factor poten-
tially leading to hypernatremia.
Signs of dehydration were noted in the medical
records in 44.6% (25/56) of dogs and 90% (18/20) of
cats at the time moderate or severe hypernatremia was
identified. No overhydrated dogs and cats were identi-
fied in this population. Of dogs with moderate or severe
hypernatremia, 26.8% (15/56) showed clinical signs of
hypovolemia, 71.4% (40/56) were considered euvolemic,
and 1.8% (1/56) had signs of hypervolemia. In cats,
55% (11/20) showed signs of hypovolemia, while 45%
(9/20) were considered euvolemic when hypernatremia
was first identified. No hypervolemic cats were identi-
fied.
The most frequent clinical signs of dogs when moder-
ate or severe hypernatremia were identified included
obtundation (27/56, 48.2%), vomiting (22/56, 39.3%),
and lethargy (7/56, 25%). Cats with moderate or severe
hypernatremia showed lethargy (13/23, 56.5%), obtun-
dation (13/23, 56.5%), and vomiting (8/23, 34.8%) at
the time of diagnosis (Table 4).
Discussion
In this study, the overall case fatality rates of dogs
and cats with hypernatremia was significantly higher
than those animals with a normal sodium concentra-
tion. In addition, case fatality rate linearly increased
with increasing sodium concentration. An increased risk
of death in animals with hypernatremia in this study
was present even with borderline abnormalities (a
sodium concentration ≥5 mmol/L higher than the high-
B
A
Fig 1. Percent death among various degrees of hypernatremia in
dogs (A) and cats (B). There is a linear association of increasing
case fatality rate with greater hypernatremia P < .0001. Hypernat-
remia was categorized as borderline (≤5 mmol/L higher than the
highest reference concentration), mild (6–10 mmol/L higher than
the highest reference concentration), moderate (11–15 mmol/L
higher than the highest reference concentration), or severe
(≥16 mmol/L higher than the highest reference concentration). The
white area of each column represents the percentage of survivors
and the black area represents the percentage of death.
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est reference concentration). There are similar relation-
ships in human patients at hospital admission, in
patients hospitalized in the general ward as well as in
ICU patients.2,10,11,13,14 All of these human studies have
found an independent effect of ICU-acquired hypernat-
remia on death after adjusting for other risk factors.
However, it is unknown if hypernatremia has a direct
effect on death or if it is purely a marker of disease
severity. Previous human studies demonstrated that
concomitant sepsis or pneumonia and increasing rates
of fluid replacement were important prognostic indica-
tors of death with hypernatremia.4,15–17 On the other
hand, the hyperosmolar state associated with hypernat-
remia alters a variety of cellular functions, which might
contribute to metabolic, neurological, and cardiovascu-
lar complications.2,18–20 Therefore, the association of
Table 2. Primary disease processes of dogs and cats identified with moderate or severe hypernatremia. Note, indi-
vidual animals may have >1 condition.
Primary Disease
Processes
Dogs with Hypernatremia
N (%)
Cats with Hypernatremia
N (%)
Moderate Severe Total Moderate Severe Total
Total 29 27 56 10 10 20
Neurological 5 (17.2) 9 (33.3) 14 (25) 2 (20) 3 (30) 5 (25)
Neoplasia 6 (20.7) 6 (22.2) 12 (21.4) 1 (10) 0 1 (5)
Respiratory 7 (24.1) 4 (14.8) 11 (19.6) 0 2 (20) 2 (10)
Hepatobiliary 6 (20.7) 4 (14.8) 10 (17.9) 2 (20) 1 (10) 3 (15)
Gastrointestinal 5 (17.2) 2 (7.4) 7 (12.5) 0 (6) 1 (10) 1 (5)
Urological 5 (17.2) 2 (7.4) 7 (12.5) 5 (50) 6 (60) 11 (55)
Pancreatic 1 (3.5) 5 (18.5) 6 (10.7) 0 0 0
DM/DKA 5 (17.2) 0 5 (8.9) 0 0 0
Musculoskeletal 1 (3.5) 2 (7.1) 3 (5.4) 0 0 0
Cardiovascular 0 2 (7.4) 2 (3.6) 0 1 (10) 1 (5)
Reproductive 0 0 0 0 0 0
Sepsis 0 0 0 1 (10) 1 (10) 2 (10)
DM, diabetes mellitus; DKA, diabetic ketoacidosis.
Moderate hypernatremia, 11–15 mmol/L higher than the highest reference concentration; severe hypernatremia, ≥16 mmol/L higher than
the highest reference concentration.
Table 3. Potential pathophysiologic factors that might have contributed to development of hypernatremia in dogs
and cats identified with moderate or severe hypernatremia. Note that individual animals may have >1 condition.
Pathophysiologic
Factors
Dogs with Hypernatremia
N (%)
Cats with Hypernatremia
N (%)
Moderate Severe Total Moderate Severe Total
Total 29 27 56 10 10 20
GI loss 12 (41.4) 10 (37) 22 (39.3) 2 (20) 3 (30) 5 (25)
CDI 2 (6.9) 11 (40.7) 13 (23.2) 0 0 0
Fever/Hyperthermia 5 (17.2) 8 (29.6) 13 (23.2) 0 1 (10) 1 (5)
NDI 5 (17.2) 1 (3.7) 6 (10.7) 0 0 0
DM/DKA 4 (13.8) 1 (3.7) 5 (8.9) 0 0 0
Hyperadrenocorticism 1 (3.4) 3 (11.1) 4 (7.1) 0 0 0
Mannitol infusion 2 (6.9) 2 (7.4) 4 (7.1) 0 0 0
Nonoliguric acute renal failure 2 (6.9) 1 (3.7) 3 (5.4) 3 (30) 2 (20) 5 (25)
Hypertonic fluid administration 2 (6.9) 1 (3.7) 3 (5.4) 1 (10) 0 0
Third space loss 2 (6.9) 1 (3.7) 3 (5.4) 0 0 0
Primary hypodipsia 0 2 (7.4) 2 (3.6) 0 0 0
Chronic renal failure 0 1 (3.7) 1 (1.8) 3 (30) 3 (30) 6 (30)
Diuretic administration 0 1 (3.7) 1 (1.8) 0 0 0
Postobstructvive diuresis 0 0 0 0 1 (10) 1 (5)
Inadequate access to water 0 0 0 1 (10) 0 1 (5)
Cutaneous loss 0 0 0 0 0 0
Salt poisoning 0 0 0 0 0 0
Hyperaldosteronism 0 0 0 0 0 0
Unknown 6 (20.7) 4 (14.8) 10 (17.9) 4 (40) 2 (20) 6 (30)
CDI, central diabetes insipidus; DM, diabetes mellitus; DKA, diabetic ketoacidosis GI, gastrointestinal; NDI, neprhogenic diabetes in-
sipidus.
Moderate hypernatremia, 11–15 mmol/L higher than the highest reference concentration; severe hypernatremia, ≥16 mmol/L higher than
the highest reference concentration.
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hypernatremia with death is likely to be a combination
of the effects of underlying organ dysfunction and harmful
consequences of the hypernatremia itself. Interestingly, a
recent study found that correction of hypernatremia was
associated with improved survival in critically ill human
patients.21 This finding also might imply that hypernatre-
mia directly affects human patient death.
Although hypernatremia in this group of dogs and
cats was much less common than hyponatremia in the
same population, it was associated with a higher case
fatality rate.12 Hypernatremia was uncommon in non-
critically ill human patients with a prevalence of 0.2%
upon admission and 1.0% for patients developing it
during their hospital stays.3 In contrast, hypernatremia
is a relatively common finding in critically ill human
patients treated in ICU.2,6,7,13,14 The overall incidence
of hypernatremia in this study was similar to that
reported in human studies. However, as this study
included a wide variety of animal types, it was difficult
to directly compare these results with human studies.
Hypernatremia is more commonly acquired during
hospitalization than it is to develop before admis-
sion.3,5,7,11 In human patients, elderly persons with
infirmity or febrile illness and infants with diarrhea
have the highest risk of developing community-
acquired hypernatremia.4,17,19 The majority of human
patients who develop hypernatremia during hospitaliza-
tion have pure water or hypotonic fluid loss in urine
because of urine concentration defects, primarily as a
results of the use of diuretics or solute diuresis.3,7–9,22
In this study, hospital acquired moderate or severe hy-
pernatremia was as common as community-acquired
hypernatremia in dogs. While in cats with moderate or
severe hypernatremia, hospital-acquired was more com-
mon than community-acquired hypernatremia.
Although the proportion of hospital-acquired com-
pared to community-acquired hypernatremia in human
patients is higher than those in dogs and cats, the
trend is similar. Hospital-acquired hypernatremia
might be associated with the medical and fluid therapy
provided by clinicians.3,8,23
There were a large variety of primary disease pro-
cesses identified in this group of dogs and cats with
hypernatremia, although it is not possible in this study
to determine the relationship between underlying disease
and development of hypernatremia. Of the primary dis-
ease processes, neurological and urological diseases have
well-identified mechanisms by which they can cause hy-
pernatremia. Neurological disease in this study included
animals with intracranial, spinal and peripheral neuro-
logical abnormalities. Abnormal mentation or decreased
mobility might limit an animal’s access to water, which
can promote the development of hypernatremia. In
addition, intracranial diseases can result in CDI, if they
involve the hypothalamus, caudal pituitary gland or
both.1,2,24 Neurological disease is also well recognized
in human patients as a risk factor for development of
hypernatremia.25 It is important to note that hypernat-
remia can cause neurological abnormalities and it was
not possible in this study to differentiate neurological
signs caused by the primary disease versus those that
might have occurred secondary to hypernatremia.
In cats with moderate or severe hypernatremia, uro-
logical diseases were the most common primary disease
process (55%). Several factors can contribute to the
development of hypernatremia in urological diseases,
including osmotic diuresis resulting from increased sol-
ute excretion in the remaining functioning nephrons,
decreased tubular responsiveness to ADH (partial
nephrogenic diabetes insipidus [NDI]), and interference
with the countercurrent mechanism in disorders affect-
ing the renal medulla. The result might be excess hypo-
tonic fluid loss into the urine.1,2,24 Urological disease
was not as common in hypernatremic dogs (12.5%)
compared to cats, and this might reflect a lower inci-
dence of renal disease in dogs compared to cats in our
hospital population, or it might mean that the nature of
renal disease in the dog differs from the cat.
In this study, 39% of dogs and 25% of cats with
moderate or severe hypernatremia had episodes of GI
signs such as vomiting and diarrhea. In a human study,
35% of hypernatremic patients in hospital had
Table 4. Clinical signs present at the time of identification of moderate or severe hypernatremia in dogs and cats.
Note that individual animals may have >1 clinical sign.
Clinical Signs
Dogs with Hypernatremia
N (%)
Cats with Hypernatremia
N (%)
Moderate Severe Total Moderate Severe Total
Total 29 27 56 10 10 20
Obtundation 15 (51.7) 12 (44.4) 27 (48.2) 5 (50) 7 (70) 12 (60)
Vomiting 13 (44.8) 9 (33.3) 22 (39.3) 2 (20) 3 (30) 5 (25)
Lethargy 7 (24.1) 7 (25.9) 14 (25) 7 (20) 5 (50) 12 (60)
Ataxia 4 (13.8) 6 (22.2) 10 (17.9) 0 2 (20) 2 (10)
Weakness 5 (17.2) 5 (18.5) 10 (17.9) 0 3 (30) 3 (15)
Stuporous 4 (13.8) 5 (18.5) 9 (16.1) 2 (20) 2 (20) 4 (20)
Seizure 3 (10.3) 5 (18.5) 8 (14.3) 0 1 (10) 1 (5)
Tremor 3 (10.3) 2 (7.4) 5 (8.9) 0 0 0
Comatose 2 (6.9) 0 2 (3.6) 0 0 0
None 3 (10.3) 5 (18.5) 8 (14.3) 1 (10) 0 1 (5)
Moderate hypernatremia, 11–15 mmol/L higher than the highest reference concentration; severe hypernatremia ≥16 mmol/L higher than
the highest reference concentration.
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increased gastrointestinal fluid loss.3 Fluid deficits were
evident in many animals with hypernatremia in this
study. Twenty-seven percent of dogs and 55% of cats
were considered hypovolemic and 45% of dogs and
87% of cats with moderate or severe hypernatremia
had signs of dehydration on physical examination when
hypernatremia was identified. As body fluid loss can be
hypertonic, isotonic or hypotonic, dehydration and hyp-
ovolemia can occur in association with a normal,
increased or decreased sodium concentration.1 Sodium
concentration might be further altered by the quantity of
water intake. As a result, serum sodium concentration is
not a sensitive marker of dehydration or hypovolemia.
Gastrointestinal signs are common in many different pri-
mary disease processes and might explain how hypernat-
remia occurs in diseases such as neoplasia, where a
direct cause of hypernatremia might not be obvious.
Insensible fluid loss from the respiratory tract is gener-
ally hypotonic to plasma. In people, 55% of hypernatre-
mia patients in one study had signs of increased insensible
hypotonic fluid losses because of fever, hyperthermia, and
respiratory diseases.3 Fever and hyperthermia were also
one of the common potential pathophysiologic factors
seen in dogs with moderate or severe hypernatremia in
this study (23.2%). The reference range of insensible
water loss in dogs is between 20.5–26.2 ml/kg/d depend-
ing on the physiologic condition and diet.1 Fever or
hyperthermia results in increased rate of water evapora-
tion and minute ventilation, and thereby increase loss via
the skin or lungs.24 It is also possible that human patients
with fever or hyperthermia might have decreased water
intake because of illness or altered mentation, further
contributing to the development of hypernatremia.
In our study, 23% of dogs with moderate or severe hy-
pernatremia were diagnosed with CDI and 11% were
diagnosed with NDI. Central diabetes insipidus is caused
by partial or complete lack of ADH production and
release from the neurohypophysis. It might result from
head trauma, pituitary malformation, cysts, encephalitis,
or neoplasia or might be idiopathic in dogs and cats.26–29
Congenital CDI is rare, but has been reported in case
reports.30,31 Nephrogenic diabetes insipidus is a congeni-
tal or acquired disorder in which hypothalamic function
and ADH release are normal, but the ability to concen-
trate the urine is reduced because of diminished or
absent renal responsiveness to ADH. Congenital NDI is
a rare disorder in small animals.32 There are various
causes of acquired NDI reported in human patients and
small animals.1,24,33 It is important to note that the
majority of these animals maintain water balance with a
near normal sodium concentration if their thirst mecha-
nism is intact and an adequate amount of water is pro-
vided. Hypernatremia develops when the thirst
mechanism or access to water are compromised. Central
and nephrogenic diabetes insipidus were not reported in
cats in this study population. As the diagnosis of diabe-
tes insipidus requires specific tests, it is likely that it
would be under recognized in this retrospective study.
The clinical signs associated with hypernatremia are
primarily neurological as a consequence of water move-
ment out of brain cells. Studies in experimental animals
and in humans have revealed that this decrease in brain
volume causes rupture of the cerebral veins, resulting in
focal intracerebral and subarachnoid hemorrhages.19,34
The severity of clinical signs are related more to the
rapidity of onset of hypernatremia than to the magni-
tude of hypernatremia. If hypernatremia develops
slowly, the brain has time to adapt to the hypertonic
state by production of intracellular solutes and thus
human patients with chronic hypernatremia are rela-
tively asymptomatic.35 Clinical signs of acute hypernat-
remia include anorexia, lethargy, vomiting, muscular
weakness, disorientation, ataxia, seizure, coma, and
death.19,36,37 In this study, the common clinical signs
evident in animals with moderate or severe hypernatre-
mia were obtundation (48.2% in dogs, 60% in cats),
vomiting (39.3% in dogs, 25% in cats), lethargy (25%
in dogs, 60% in cats), weakness (17.9% in dogs, 15%
in cats), and ataxia (17.9% in dogs, 10% in cats). Some
animals also showed more severe clinical signs such as
stupor, coma, tremors, and seizures. However, as previ-
ously mentioned, clinical signs because of hypernatre-
mia could not be differentiated from clinical signs of
the underlying disease in this study.
Our study has limitations inherent to a retrospective
study. The direct and indirect effects of medical inter-
ventions on serum sodium concentration could not be
determined. Similarly, possible causes and clinical signs
of hypernatremia were identified in this study, but there
was no way to confirm any relationship between these
findings and the occurrence of hypernatremia. The true
incidence of hypernatremia in dogs and cats cannot be
determined by this study, because only animals that had
a blood or serum sodium concentration analyzed were
included. A prospective study in which all animals
presenting to a veterinary facility would have blood or
serum sodium concentration measured on admission
and followed during the hospital stay would be ideal.
In conclusion, hypernatremia was an infrequent
abnormality in both dogs and cats at a veterinary medi-
cal teaching hospital. Hospital-acquired hypernatremia
was as common as community-acquired hypernatremia
in dogs, and it was more common than community-
acquired hypernatremia in cats. The overall case fatality
rate of animals with hypernatremia was significantly
higher than that of animals with a normal sodium con-
centration or those with hyponatremia. A significant
linear association withwards higher case fatality rate
with greater hypernatremia in both dogs and cats was
found, with even borderline hypernatremia associated
with an increased case fatality rate. Future studies to
identify the causes of hypernatremia in animals and the
potential benefit of prevention or treatment of this
abnormality are warranted.
Footnotes
a ABL 705, Radiometer Medical A/S, Copenhagen, Denmark
b Chemistry analyzer, Hitachi 917, Roche Diagnostics, Indianapo-
lis, IN
Hypernatremia in Dogs and Cats 799
c Chemistry analyzer, Hitachi c501, Roche Diagnostics, Indianapo-
lis, IN
d GraphPad Prism 6.0, Graph Pad Software, La Jolla, CA
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